Kalafatis: Greece produces 50% of Europe’s oncology drugs, 30% of cardio-metabolic drugs and 25% of penicillin drugs

“In a world where biomedical research, caller integer technologies and Artificial Intelligence are transforming healthcare systems, strengthening practice betwixt the state, industry, the world and probe community, and the innovation ecosystem is simply a prerequisite for sustainable maturation successful the healthcare sector,” Deputy Minister of Development liable for Research and Innovation Stavros Kalafatis said while addressing an lawsuit organized by the Hellenic Association of Pharmaceutical Companies arsenic portion of the “Innovation Meets Industry” inaugural under the theme “Innovation successful Motion.”

He added that “the inaugural deepens the dialog astir innovation successful the pharmaceutical sector, highlighting the strong momentum of the Greek pharmaceutical manufacture and its publication to caller therapies for patients.”

“For us astatine the Ministry of Development,” Kalafatis noted, “Research and Innovation are cardinal pillars supporting the country’s caller productive model, investments and the instauration of caller jobs.”

Actions Already Underway

Kalafatis besides referred to a fig of initiatives already being implemented, specifically noting that:

-The National Smart Specialisation Strategy (NSRF 2021-2027) has identified Pharmaceuticals and Health Life Sciences among its 8 cardinal sectors.

-Through the Recovery and Resilience Fund, NSRF programmes and nationalist resources, the authorities is supporting the improvement of biotechnology products, objective probe and the accumulation of high-tech pharmaceuticals.

-Cooperation betwixt probe institutions and pharmaceutical companies is being strengthened with the purpose of accelerating technology transfer and the improvement of innovative solutions.

-Greece is promoting the information of home organizations successful European and planetary networks such arsenic Horizon Europe.

-Investments are being made successful the acquisition and training of young scientists required by the pharmaceutical sector.

The lawman curate besides referred to the important advancement achieved by the Greek pharmaceutical ecosystem, “whose publication during the pandemic was decisive. It provided us with the tools to support ourselves against the coronavirus,” helium stressed.

“Following the government’s investment-friendly policies implicit the past 6 years, Greece now produces 50% of Europe’s oncology drugs, 30% of cardio-metabolic drugs and 25% of penicillin drugs. With 45 cause factories – retired of 400 successful the EU – it represents 10% of European production,” the Deputy Minister of Development pointed out, adding that: “With generous incentives that we person provided, implicit 1.5 cardinal euros person been invested successful the fields of cause probe and production, which person led to the instauration of 10 caller factories and 14 caller probe centers.”

“We person made important steps. We are determined to determination adjacent faster successful a assemblage that gives the state a competitory advantage, contributes to extroversion, employment and the productive reconstruction of the country,” the Deputy Minister of Development emphasized.